The superiority of robot in surgery of mediastinal diseases

Since 2001, when robotic technology was first approved by the US Food and Drug Administration (FDA) (1) and then introduced in clinical practice, the best targets for cardio-thoracic surgery were considered all those procedures requiring operating in tiny and/or difficult to reach spaces, where an extreme dexterity an precision of instruments are required (2).